Cord blood transplantation for haematological malignancies: Conditioning regimens, double cord transplant and infectious complications

British Journal of Haematology

Volumn 147, Issue 2, 2009, Pages 207-216

  Delaney, Colleen ^a,b   Gutman, Jonathan A ^a,b   Appelbaum, Frederick R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute leukaemia; Bone marrow transplant; Cord blood transplantation; Infection; Myelodysplastic Syndrome

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; BACTERIAL INFECTION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; GRAFT FAILURE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MYCOSIS; MYELOABLATIVE CONDITIONING; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; VIRUS INFECTION; WHOLE BODY RADIATION;

ALGORITHMS; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; HEMATOLOGIC NEOPLASMS; HUMANS; OPPORTUNISTIC INFECTIONS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 70349661964     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07782.x     Document Type: Review

References (73)

1. Arcese, W., Rocha, V., Labopin, M., Sanz, G., Iori, A.P., de Lima, M., Sirvent, A., Busca, A., Asano, S., Ionescu, I., Wernet, P. Gluckman, E. (2006) Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica, 91, 223 230.
2. Atsuta, Y., Suzuki, R., Nagamura-Inoue, T., Taniguchi, S., Takahashi, S., Kai, S., Sakamaki, H., Kouzai, Y., Kasai, M., Fukuda, T., Azuma, H., Takanashi, M., Okamoto, S., Tsuchida, M., Kawa, K., Morishima, Y., Kodera, Y. Kato, S. (2009) Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood, 113, 1631 1638.
3. Ballen, K.K., Spitzer, T.R., Yeap, B.Y., McAfee, S., Dey, B.R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, R. Antin, J.H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biology of Blood and Marrow Transplantation, 13, 82 89.
4. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., Miller, J.S. Wagner, J.E. (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 102, 1915 1919.
5. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Mille, J.S., Verfaillie, C.M. Wagner, J.E. (2005a) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 1343 1347.
6. Barker, J.N., Hough, R.E., van Burik, J.A., DeFor, T.E., MacMillan, M.L., O'Brien, M.R. Wagner, J.E. (2005b) Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biology of Blood and Marrow Transplantation, 11, 362 370.
7. Barker, J.N., Scaradavou, A., Stevens, C. Rubinstein, P. (2007) The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy. Blood, 110, a333.
8. Barker, J.N., Rocha, V. Scaradavou, A. (2008) Optimizing unrelated donor cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 154 161.
9. Brunstein, C.G., Weisdorf, D.J., DeFor, T., Barker, J.N., Tolar, J., van Burik, J.A. Wagner, J.E. (2006) Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood, 108, 2874 2880.
10. Brunstein, C.G., Barker, J.N., Weisdorf, D.J., DeFor, T.E., Miller, J.S., Blazar, B.R., McGlave, P.B. Wagner, J.E. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 3064 3070.
11. Brunstein, C., Weisdorf, D., DeFor, T., Miller, J.S., McGlave, P.B., Blazar, B.R. Wagner, J.E. (2008) Favorable leukemia-free survival (LFS) for adults and children undergoing myeloablative umbilical cord blood (UCB) transplantation with cyclophosphamide (CY), fludarabine (FLU) and total body irradiation (TBI): a single center analysis of 194 patients. Blood, 112, a1957.
12. Brunstein, C.G., Cantero, S., Cao, Q., Majhail, N., McClune, B., Burns, L.J., Tomblyn, M., Miller, J.S., Blazar, B.R., McGlave, P.B., Weisdorf, D.J. Wagner, J.E. (2009) Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 214 222.
13. Carpenter, P.A., Snyder, D.S., Flowers, M.E., Sanders, J.E., Gooley, T.A., Martin, P.J., Appelbaum, F.R. Radich, J.P. (2007) Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood, 109, 2791 2793.
14. Casper, J., Knauf, W., Kiefer, T., Wolff, D., Steiner, B., Hammer, U., Wegener, R., Kleine, H.D., Wilhelm, S., Knopp, A., Hartung, G., Dölken, G. Freund, M. (2004) Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood, 103, 725 731.
15. Ciurea, S.O. Andersson, B.S. (2009) Busulfan in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 15, 523 536.
16. Cornetta, K., Laughlin, M., Carter, S., Wall, D., Weinthal, J., Delaney, C., Wagner, J., Sweetman, R., McCarthy, P. Chao, N. (2005) Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). Biology of Blood and Marrow Transplantation, 11, 149 160. (Pubitemid 40186212)
17. Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 1947 1954.
18. Eldjerou, L.K., Chaudhury, S., He, M., Arcila, M.E., Salazar, P.A., O'Reilly, R.J., Barker, J.N. Moore, M.A.S. (2008) Graft-vs-graft immune interaction is the likely mechanism of absolute unit dominance in double unit cord blood (DCB) transplantation using patient DCB grafts: an in vivo but not in vitro phenomenon. Blood, 112, a3486.
19. Gluckman, E. Rocha, V. (2004) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis. Blood Cells, Molecules, and Diseases, 33, 271 273.
20. Gutman, J.A., Leisenring, W., Appelbaum, F.R., Woolfrey, A.E. Delaney, C. (2008) Decreased relapse rates without excessive transplant related mortality following cord blood transplantation (CBT): a matched cohort analysis comparing myeloablative cord, matched unrelated, and mismatched unrelated donor transplants. Blood, 112, a968.
21. Gutman, J.A., Turtle, C., Manley, T.J., Riddell, S.R. Delaney, C. (2009) Engraftment of a Single Unit Following Double Unit Umbilical Cord Hematopoietic Cell Transplantation Coincides with a CD8+ T Cell Response to the Non-Engrafted Unit. ISCT Annual Meeting. Oral presentation.
22. Hamza, N.S., Lisgaris, M., Yadavalli, G., Nadeau, L., Fox, R., Fu, P., Lazarus, H.M., Koc, O.N., Salata, R.A. Laughlin, M.J. (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. British Journal of Haematology, 124, 488 498.
23. Holowiecki, J., Giebel, S., Beelen, D., Trenschel, R., Wandt, H., Schaefer-Eckart, K., Ruutu, T., Volin, L., Einsele, H., Stuhler, G., Uharek, L., Blau, I., Bornhaeuser, M., Zander, A., Kroeger, N., Aschan, J., Wojnar, J., Markiewicz, M., Freund, M. Casper, J. (2007) Phase II multicenter trial to evaluate the safety and efficacy of low-toxicity treosulfan/fludarabine conditioning prior to allogeneic haematopoietic stem cell transplantation in patients with acute myeloid leukemia. Blood, 110, a621.
24. Horwitz, M.E., Morris, A., Gasparetto, C., Sullivan, K., Long, G., Chute, J., Rizzieri, D., McPherson, J. Chao, N. (2008) Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. Biology of Blood and Marrow Transplantation, 14, 591 594.
25. Kögler, G., Enczmann, J., Rocha, V., Gluckman, E. Wernet, P. (2005) High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplantation, 36, 1033 1041.
26. Konuma, T., Takahashi, S., Ooi, J., Tomonari, A., Tsukada, N., Kato, S., Sato, A., Monma, F., Kasahara, S., Nagamura-Inoue, T., Uchimaru, K., Iseki, T., Tojo, A., Yamaguchi, T. Asano, S. (2009) Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age. Annals of Hematology, 88, 581 588.
27. Kurtzberg, J., Prasad, V.K., Carter, S.L., Wagner, J.E., Baxter-Lowe, L.A., Wall, D., Kapoor, N., Guinan, E.C., Feig, S.A., Wagner, E.L. Kernan, N.A. (2008) Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood, 112, 4318 4327.
28. Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., van Rood, J.J., Scaradavou, A. Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. The New England Journal of Medicine, 351, 2265 2275.
29. Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., Messina, C., Ortega, J., Badell-Serra, I., Plouvier, E., Souillet, G., Jouet, J.P., Pasquini, R., Ferreira, E., Garnier, F. Gluckman, E. (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood, 93, 3662 3671.
30. MacMillan, M.L., Weisdorf, D.J., Brunstein, C.G., Cao, Q., DeFor, T.E., Verneris, M.R., Blazar, B.R. Wagner, J.E. (2009) Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood, 113, 2410 2415.
31. Majhail, N.S., Weisdorf, D.J., Wagner, J.E., Defor, T.E., Brunstein, C.G. Burns, L.J. (2006a) Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood, 107, 3804 3807.
32. Majhail, N.S., Brunstein, C.G. Wagner, J.E. (2006b) Double umbilical cord blood transplantation. Current Opinion in Immunology, 18, 571 575.
33. Majhail, N.S., Brunstein, C.G., Tomblyn, M., Thomas, A.J., Miller, J.S., Arora, M., Kaufman, D.S., Burns, L.J., Slungaard, A., McGlave, P.B., Wagner, J.E. Weisdorf, D.J. (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of Blood and Marrow Transplantation, 14, 282 289.
34. Matà, S., Guidi, S., Nozzoli, C., Orsi, A., Pratesi, A., Mascalchi, M., Moretti, M., Letizia, L., Rombolà, G., Sorbi, S. Bosi, A. (2008) Human herpesvirus 6-associated limbic encephalitis in adult recipients of unrelated umbilical cord blood transplantation. Bone Marrow Transplantation, 42, 693 695.
35. Matsumura, T., Narimatsu, H., Kami, M., Yuji, K., Kusumi, E., Hori, A., Murashige, N., Tanaka, Y., Masuoka, K., Wake, A., Miyakoshi, S., Kanda, Y. Taniguchi, S. (2007) Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biology of Blood and Marrow Transplantation, 13, 577 583.
36. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, C., Blume, K.G. Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 3390 3400.
37. Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K.W., Filipovich, A., Takahashi, T.A., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P.J., Yaniv, I., Machado, A., Pimentel, P., Fagioli, F., Verdeguer, A., Jouet, J.P., Diez, B., Ferreira, E., Pasquini, R., Rosenthal, J., Sievers, E., Messina, C., Iori, A.P., Garnier, F., Ionescu, I., Locatelli, F. Gluckman, E. (2003) Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood, 102, 4290 4297.
38. Miyakoshi, S., Yuji, K., Kami, M., Kusumi, E., Kishi, Y., Kobayashi, K., Murashige, N., Hamaki, T., Kim, S.W., Ueyama, J., Mori, S., Morinaga, S., Muto, Y., Masuo, S., Kanemaru, M., Hayashi, T., Takaue, Y. Taniguchi, S. (2004) Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clinical Cancer Research, 10, 3586 3592.
39. Miyakoshi, S., Kusumi, E., Matsumura, T., Hori, A., Murashige, N., Hamaki, T., Yuji, K., Uchida, N., Masuoka, K., Wake, A., Kanda, Y., Kami, M., Tanaka, Y. Taniguchi, S. (2007) Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biology of Blood and Marrow Transplantation, 13, 771 777.
40. Montesinos, P., Sanz, J., Cantero, S., Lorenzo, I., Martin, G., Saavedra, S., Palau, J., Romero, M., Montava, A., Senent, L., Martinez, J., Jarque, I., Salavert, M., Cordoba, J., Gomez, L., Weiss, S., Moscard, F., de la Rubia, J., Larrea, L., Sanz, M.A. Sanz, G.F. (2009) Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 730 740.
41. Muramatsu, H., Watanabe, N., Matsumoto, K., Ito, M., Yoshikawa, T., Kato, K. Kojima, S. (2009) Primary infection of human herpesvirus-6 in an infant who received cord blood SCT. Bone Marrow Transplantation, 43, 83 84.
42. Narimatsu, H., Matsumura, T., Kami, M., Miyakoshi, S., Kusumi, E., Takagi, S., Miura, Y., Kato, D., Inokuchi, C., Myojo, T., Kishi, Y., Murashige, N., Yuji, K., Masuoka, K., Yoneyama, A., Wake, A., Morinaga, S., Kanda, Y. Taniguchi, S. (2005) Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biology of Blood and Marrow Transplantation, 11, 429 436.
43. Narimatsu, H., Kami, M., Kato, D., Matsumura, T., Murashige, N., Kusumi, E., Yuji, K., Hori, A., Shibata, T., Masuoka, K., Wake, A., Miyakoshi, S., Morinaga, S. Taniguchi, S. (2007) Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease, 9, 11 15.
44. Narimatsu, H., Watanabe, M., Kohno, A., Sugimoto, K., Kuwatsuka, Y., Uchida, T., Murata, M., Miyamura, K. Morishita, Y. (2008) High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplantation, 41, 753 756.
45. Nemecek, E.R., Sorror, M.L., Doney, K.C., Scott, B.S., Kovacsovics, T.J., Maziarz, R.T., Woolfrey, A.E., Sanders, J., O'Donnell, P.V., Guthrie, K. Deeg, H.J. (2008) A regimen of treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation (HCT) for high-risk hematologic malignancies is associated with low treatment-related mortality. Blood, 112, a2994.
46. Okada, M., Fujimori, Y., Misawa, M., Kai, S., Nakajima, T., Okikawa, Y., Satake, A., Itoi, H., Takatsuka, H., Itsukuma, T., Nishioka, K., Tamaki, H., Ikegame, K., Hara, H. Ogawa, H. (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biology of Blood and Marrow Transplantation, 14, 896 903.
47. Ooi, J., Takahashi, S., Tomonari, A., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Sato, A., Monma, F., Nagamura, F., Iseki, T., Tojo, A. Asano, S. (2008) Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia. Biology of Blood and Marrow Transplantation, 14, 1341 1347.
48. Ooi, J., Takahashi, S., Tomonari, A., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Sato, A., Monma, F., Nagamura, F., Iseki, T., Tojo, A. Asano, S. (2009) Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL. Bone Marrow Transplantation, 43, 455 459.
49. Parody, R., Martino, R., Rovira, M., Vazquez, L., Vázquez, M.J., de la Cámara, R., Blazquez, C., Fernández-Avilés, F., Carreras, E., Salavert, M., Jarque, I., Martín, C., Martínez, F., López, J., Torres, A., Sierra, J. Sanz, G.F. (2006) Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biology of Blood and Marrow Transplantation, 12, 734 748.
50. Peters, W.P., Henner, W.D., Grochow, L.B., Olsen, G., Edwards, S., Stanbuck, H., Stuart, A., Gockerman, J., Moore, J., Bast, Jr., R.C., Seigler, H.F. Colvin, O.M. (1987) Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. Cancer Research, 47, 6402 6406.
51. Rocha, V., Wagner, J.E., Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine, 342, 1846 1854.
52. Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood, 97, 2962 2971.
53. Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., de Lima, M., Finke, J., Frassoni, F. Gluckman, E. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. The New England Journal of Medicine, 351, 2276 2285.
54. Rodrigues, C.A., Sanz, G., Brunstein, C.G., Sanz, J., Wagner, J.E., Renaud, M., de Lima, M., Cairo, M.S., Fürst, S., Rio, B., Dalley, C., Carreras, E., Harousseau, J.L., Mohty, M., Taveira, D., Dreger, P., Sureda, A., Gluckman, E. Rocha, V. (2009) Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology, 27, 256 263.
55. Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellits, D., Sensenbrenner, L.L., Stuart, R.K. Yeager, A.M. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. The New England Journal of Medicine, 309, 1347 1353.
56. Sanz, J., Arcese, W., Hernandez-Boluda, J.C., Ferra, C., Gonzalez, M., Martin, C., Serrano, D., Cordoba, R., Picardi, A., Solano, C., Sanz, M.A. Sanz, G. (2007) Low transplant-related mortality in patients with hematologic malignancies undergoing umbilical cord blood transplantation (UCBT) with thiotepa (TT), once-daily intravenous (IV) busulfan (BU), fludarabine (FLU) and anti-thymocyte globulin (ATG). Blood, 110, a618.
57. Shereck, E.B., Cooney, E., van de Ven, C., Della-Lotta, P. Cairo, M.S. (2007) A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatric Blood & Cancer, 49, 306 312.
58. Takahashi, S., Ooi, J., Tomonari, A., Konuma, T., Tsukada, N., Oiwa-Monna, M., Fukuno, K., Uchiyama, M., Takasugi, K., Iseki, T., Tojo, A., Yamaguchi, T. Asano, S. (2007) Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood, 109, 1322 1330.
59. Takami, A., Mochizuki, K., Asakura, H., Yamazaki, H., Okumura, H. Nakao, S. (2005) High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. Haematologica, 90, 1290 1292.
60. Tanaka, M., Taguchi, J., Hyo, R., Kawano, T., Hashimoto, C., Motomura, S., Kodama, F., Kobayashi, S., Okabe, G., Maruta, A., Nagao, T. Ishigatsubo, Y. (2005) Human herpesvirus-6 encephalitis after unrelated cord blood transplantation. Leukaemia & Lymphoma, 46, 561 566.
61. Tomonari, A., Takahashi, S., Ooi, J., Iseki, T., Takasugi, K., Uchiyama, M., Konuma, T., Futami, M., Ohno, N., Uchimaru, K., Tojo, A. Asano, S. (2005) Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation. International Journal of Hematology, 81, 352 355. (Pubitemid 41702100)
62. Tomonari, A., Takahashi, S., Ooi, J., Nakaoka, T., Takasugi, K., Uchiyama, M., Tsukada, N., Konuma, T., Iseki, T., Tojo, A. Asano, S. (2006) Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. European Journal of Haematology, 77, 46 50.
63. Tomonari, A., Takahashi, S., Ooi, J., Tsukada, N., Konuma, T., Kato, S., Kasahara, S., Iseki, T., Yamaguchi, T., Tojo, A. Asano, S. (2008a) Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. European Journal of Haematology, 80, 251 257.
64. Tomonari, A., Takahashi, S., Ooi, J., Tsukada, N., Konuma, T., Kobayashi, T., Takasugi, K., Iseki, T., Tojo, A. Asano, S. (2008b) Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplantation, 41, 371 376.
65. Tutschka, P.J., Copelan, E.A. Klein, J.P. (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood, 70, 1382 1388.
66. Vandenbosch, K., Ovetchkine, P., Champagne, M.A., Haddad, E., Alexandrov, L. Duval, M. (2008) Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biology of Blood and Marrow Transplantation, 14, 867 871.
67. Verneris, M.V., Brunstein, C., DeFor, T.E., Barker, J., Weisdorf, D.J., Blazar, B.R., Miller, J.S. Wagner, J.E. (2005) Risk of relapse (REL) after umbilical cord blood transplantation (UCBT) in patients with acute leukemia: marked reduction in recipients of two units. Blood, 106, 305.
68. Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 1611 1618.
69. Walker, C.M., van Burik, J.A., De For, T.E. Weisdorf, D.J. (2007) Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biology of Blood and Marrow Transplantation, 13, 1106 1115.
70. Wall, D.A., Carter, S.L., Kernan, N.A., Kapoor, N., Kamani, N.R., Brochstein, J.A., Frangoul, H., Goyal, R.K., Horan, J.T., Pietryga, D., Wagner, J.E. Kurtzberg, J. (2005) Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biology of Blood and Marrow Transplantation, 11, 637 646.
71. Waller, A.F., Wang, F. Waller, N. (2007) A mathematical model of stochastic engraftment by non-interacting single umbilical cord blood (UCB) grafts predicts accelerated engraftment using multiple UCB grafts. Blood, 110, a2034.
72. Yamada, M.F., Miyamura, K., Fujiwara, T., Kohata, K., Okitsu, Y., Ohguchi, H., Yamamoto, J., Yokoyama, H., Tomiya, Y., Ishizawa, K., Kameoka, J. Harigae, H. (2008) Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis. Transplantation Proceedings, 40, 3637 3642.
73. Yazaki, M., Atsuta, Y., Kato, K., Kato, S., Taniguchi, S., Takahashi, S., Ogawa, H., Kouzai, Y., Kobayashi, T., Inoue, M., Kobayashi, R., Nagamura-Inoue, T., Azuma, H., Takanashi, M., Kai, S., Nakabayashi, M. Saito, H. (2009) Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation, 15, 439 446.